LON:EDEN - Eden Research Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 11 0.00 (0.00 %) (As of 05/20/2019 01:28 PM ET)Previous CloseGBX 11Today's RangeGBX 10.55 - GBX 10.5552-Week RangeGBX 9 - GBX 13.92Volume7,000 shsAverage Volume70,119 shsMarket Capitalization£22.79 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides various plant protection products, such as foliar disease control, soil pest, protected glass house crops, and post-harvest applications. It also offers treatment for various pathogens that effect animal health, as well as provides animal health products, such as shampoos, conditioners, odour controls, flea and tick controls, hygiene products, parasite treatments, and insect sprays. In addition, the company offers human health products comprising head-lice, fragrances, wound-care, and food flavorings. Further, it provides a range of natural and synthetic active ingredients, including pesticides, as well as biocides. The company was incorporated in 1995 and is headquartered in Cirencester, the United Kingdom. Receive EDEN News and Ratings via Email Sign-up to receive the latest news and ratings for EDEN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Agricultural Chemicals Sub-IndustryN/A SectorBasic Materials Current SymbolLON:EDEN Previous Symbol CUSIPN/A CIKN/A Webwww.edenresearch.com Phone+44-1285-359555Debt Debt-to-Equity RatioN/A Current Ratio3.90 Quick Ratio3.80Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£2.77 million Price / Sales8.22 Cash FlowGBX 1.17 per share Price / Cash Flow9.42 Book ValueGBX 4 per share Price / Book2.75Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees5 Outstanding Shares207,188,992Market Cap£22.79 million Next Earnings Date5/22/2019 (Estimated) OptionableNot Optionable Eden Research (LON:EDEN) Frequently Asked Questions What is Eden Research's stock symbol? Eden Research trades on the London Stock Exchange (LON) under the ticker symbol "EDEN." When is Eden Research's next earnings date? Eden Research is scheduled to release their next quarterly earnings announcement on Wednesday, May 22nd 2019. View Earnings Estimates for Eden Research. Has Eden Research been receiving favorable news coverage? Media headlines about EDEN stock have been trending somewhat negative recently, InfoTrie reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Eden Research earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. Who are some of Eden Research's key competitors? Some companies that are related to Eden Research include Wynnstay Group (WYN), Evogene (EVGN), SenesTech (SNES), China Green Agriculture (CGA), Arcadia Biosciences (RKDA), Bion Environmental Technologies (BNET), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT), Monsanto (MON), Syngenta (SYT) and Terra Nitrogen (TNH). What other stocks do shareholders of Eden Research own? Based on aggregate information from My MarketBeat watchlists, some companies that other Eden Research investors own include Kromek Group (KMK), Cabot Energy (CAB), National Grid (NG), Ophir Energy (OPHR), Marston's (MARS), Mothercare (MTC), Synopsys (SNPS), Gigamon (GIMO), AFC Energy (AFC) and Glencore (GLEN). Who are Eden Research's key executives? Eden Research's management team includes the folowing people: Mr. Sean M. Smith, CEO & DirectorMr. Alexander John Abrey, CFO, Sec. & Director How do I buy shares of Eden Research? Shares of EDEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Eden Research's stock price today? One share of EDEN stock can currently be purchased for approximately GBX 11. How big of a company is Eden Research? Eden Research has a market capitalization of £22.79 million and generates £2.77 million in revenue each year. Eden Research employs 5 workers across the globe. What is Eden Research's official website? The official website for Eden Research is http://www.edenresearch.com/. How can I contact Eden Research? Eden Research's mailing address is Priory Crt Business Park, 6 Priory Court, CIRENCESTER, GL7 5JB, United Kingdom. The company can be reached via phone at +44-1285-359555. MarketBeat Community Rating for Eden Research (LON EDEN)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 101 (Vote Outperform)Underperform Votes: 116 (Vote Underperform)Total Votes: 217MarketBeat's community ratings are surveys of what our community members think about Eden Research and other stocks. Vote "Outperform" if you believe EDEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EDEN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: How mutual funds make money Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.